Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications Wolraich ML; Wibbelsman CJ; Brown TE; Evans SW; Gotlieb EM; Knight JR; Ross EC; Shubiner HH; Wender EH; Wilens TPediatrics 2005[Jun]; 115 (6): 1734-46Attention-deficit/hyperactivity disorder (ADHD) is the most common mental disorder in childhood, and primary care clinicians provide a major component of the care for children with ADHD. However, because of limited available evidence, the American Academy of Pediatrics guidelines did not include adolescents and young adults. Contrary to previous beliefs, it has become clear that, in most cases, ADHD does not resolve once children enter puberty. This article reviews the current evidence about the diagnosis and treatment of adolescents and young adults with ADHD and describes how the information informs practice. It describes some of the unique characteristics observed among adolescents, as well as how the core symptoms change with maturity. The diagnostic process is discussed, as well as approaches to the care of adolescents to improve adherences. Both psychosocial and pharmacologic interventions are reviewed, and there is a discussion of these patients' transition into young adulthood. The article also indicates that research is needed to identify the unique adolescent characteristics of ADHD and effective psychosocial and pharmacologic treatments.|*Attention Deficit Disorder with Hyperactivity/diagnosis/drug therapy/epidemiology/therapy[MESH]|Adolescent[MESH]|Antidepressive Agents/therapeutic use[MESH]|Atomoxetine Hydrochloride[MESH]|Automobile Driving[MESH]|Case Management[MESH]|Central Nervous System Stimulants/therapeutic use[MESH]|Child[MESH]|Clonidine/therapeutic use[MESH]|Comorbidity[MESH]|Continuity of Patient Care[MESH]|Family Health[MESH]|Female[MESH]|Forecasting[MESH]|Health Services Accessibility[MESH]|Humans[MESH]|Insurance Coverage[MESH]|Intellectual Disability/epidemiology[MESH]|Male[MESH]|Mental Disorders/epidemiology[MESH]|Patient Compliance[MESH]|Propylamines/therapeutic use[MESH]|Puberty[MESH]|Risk[MESH]|Substance-Related Disorders/epidemiology/etiology[MESH] |